Jeil Pharmaceutical Co. Ltd. | Cash Flow
Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
2,098
2,095
9,761
7,890
519,341
7,302
Depreciation, Depletion & Amortization
8,370
8,544
8,465
7,484
3,437
1,659
Other Funds
-
-
-
-
13,204
3,039
Funds from Operations
9,422
20,367
19,392
16,929
523,823
5,921
Changes in Working Capital
4,567
23,560
15,941
5,566
4,682
9,248
Net Operating Cash Flow
13,989
3,194
3,451
11,363
5,930
3,327
Capital Expenditures
2,396
4,793
7,053
30,327
2,971
Sale of Fixed Assets & Businesses
58
296
38
5,011
2
Purchase/Sale of Investments
1,710
6,732
1,859
326
441
Net Investing Cash Flow
3,746
2,235
4,707
24,884
3,801
Cash Dividends Paid - Total
787
515
773
764
891
Issuance/Reduction of Debt, Net
10,376
1,627
10,718
30,612
9,705
Net Financing Cash Flow
14,181
1,083
6,821
29,848
23,800
Net Change in Cash
4,043
397
5,423
16,532
21,736
Free Cash Flow
11,956
6,355
3,290
18,879
2,991
Net Assets from Acquisitions
-
-
-
500
-
Other Sources
302
-
450
731
195
Change in Capital Stock
3,017
28
3,124
-
-
Exchange Rate Effect
106
272
142
205
65
Extraordinaries
-
-
-
-
513,210
-
About Jeil Pharmaceutical Co.
View Profile
